Rowan Chapman is a co-founder of BEVC Management LLC, the Berkeley-based firm behind Bakar Entrepreneurship Fund I. See sector focus and stage focus.
Rowan Chapman is a co-founder of BEVC Management LLC, the Berkeley-based firm behind Bakar Entrepreneurship Fund I, and is listed among the fund’s directors. BEVC is described as an early-stage venture firm associated with UC Berkeley and UCSF, and its stated focus has included life science and climate-oriented investing. Publicly available materials indicate the fund was raised in 2023 with a $50 million close. BEVC’s tracked investments include Radar Therapeutics, Montara Therapeutics, PinkDx, and Addition Therapeutics. Separate coverage also notes BEVC invested in Radar Therapeutics and Insamo, and that the firm planned to expand from human health into planetary health. Chapman’s background includes a PhD in biochemistry and molecular biology, plus prior leadership roles at Johnson & Johnson and GE Ventures. Publicly available sources do not verify a typical check size, lead/follow pattern, or a detailed written investment thesis beyond the early-stage and life-science/climate emphasis.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Berkeley.
Investors like Rowan Chapman · Full investor directory · Investor access · Company funding database